Patents by Inventor Glenn Swartz

Glenn Swartz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070105903
    Abstract: The present invention comprises a group of compounds that effectively inhibit angiogenesis. More specifically, nitrogen-substituted thalidomide analogs and di-substituted thalidomide analogs have been shown to inhibit angiogenesis. Importantly, these compounds can be administered orally.
    Type: Application
    Filed: August 29, 2006
    Publication date: May 10, 2007
    Inventors: Anthony Treston, Jamshed Shah, Robert D'Amato, Barry Conner, Kimberly Hunsucker, John Rougas, Glenn Swartz, Victor Pribluda
  • Publication number: 20060013890
    Abstract: The present invention is related to naturally occurring immunoglobulin to cholesterol found in bovine milk that binds to cholesterol, LDL, IDL, and VLDL cholesterol. Milk and dairy-derived products containing immunoglobulin to cholesterol is internally administered to animals including humans. The composition is effective in lowering blood cholesterol and phospholipids by preventing the absorption of dietary sources of cholesterol in the gastrointestinal tract.
    Type: Application
    Filed: June 23, 2005
    Publication date: January 19, 2006
    Inventors: Shawn Green, Glenn Swartz
  • Publication number: 20050004087
    Abstract: The present invention comprises a group of compounds that effectively inhibit angiogenesis. More specifically, the invention comprises the compound EM-138 and its use in the inhibition of angiogenesis and treatment of angiogenesis associate diseases, including the inhibition of tumor growth and metastasis.
    Type: Application
    Filed: July 21, 2004
    Publication date: January 6, 2005
    Inventors: Robert D'Amato, Shawn Green, Glenn Swartz, Jamshed Shah, John Madsen